http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-T70162-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6bd764477f277ef3f941a5661a06988 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D503-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 1993-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5452ae822b0f2d2590237205f01ce486 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3256af8f736dfb317fca7cbd24602698 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28a3b662cc05958f8d83bbe9ec771fd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3d5c27336fd68e31561d22bd9604deb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_548ef2565a8bfdd60af3c6532e4cfdca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e36ca8534de4086868a05df6776edb01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_949311e8727b8393d0ddc9bb2da6bd91 |
| publicationDate | 1995-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-T70162-A |
| titleOfInvention | Process for producing pharmaceutical compositions containing 4-oxa-1-azabicyclo[3,2,0]heptan-7-one derivatives as antitumor agents |
| abstract | The present invention relates to the use of 4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives of formula (I) or a pharmaceutically acceptable salt thereof, as antitumor agents, wherein R is -OCOR1 group wherein R1 is hydrogen atom, a C1-9 alkyl group which may be substituted by either one or two substituents selected together from halogen atom, hydroxy, carboxy group or (3RS, 5SR)-(4-oxa-1-azabicyclo[3,2,0]heptan-7-one-3-yl)methyloxycarbonyl, a C2-17 alkenyl group, which may be substituted by carboxy group or (3RS, 5SR)-(4-oxa-1-azabicyclo[3,2,0]heptan-7-one-3-yl)methyloxycarbonyl, a C2-4 alkynyl group, a C3-6 cycloalkyl group which may be substituted by carboxy group or phenyl group which may have 1, 2 or 3 substituents selected from the group consisting of cyano group, halogen atom, C1-6 alkoxy group which may be substituted by carboxy group, C1-6 alkyl group, amino group or hydroxy group. -OR2 wherein R2 is a hydrogen atom or benzyl group which may be substituted by 1 or 2 C1-6 alkoxy group. -S(O)nR3 wherein R3 is phenyl group or a benzyl group which may be substituted by C1-6 alkyl group, n is 0, 1 or 2; or -CH2OH. |
| priorityDate | 1992-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 182.